Advertisement

Reactions Weekly

, Volume 1722, Issue 1, pp 265–265 | Cite as

Osimertinib

Fatigue and stomatitis: 2 case reports
Case report
  • 15 Downloads

Reference

  1. Furuta H, et al. Efficacy and safety data of osimertinib in elderly patients with NSCLC who harbor the EGFR T790M mutation after failure of initial EGFR-TKI treatment. Anticancer Research 38: 5231-5237, No. 9, Sep 2018. Available from: URL: http://doi.org/10.21873/anticanres.12847 - Japan

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations